Wealth Enhancement Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.29M | Sell |
9,662
-24,083
| -71% | -$13.2M | 0.01% | 872 |
|
|
2025
Q1 | $21.4M | Sell |
33,745
-12,246
| -27% | -$7.77M | 0.04% | 378 |
|
|
2024
Q4 | $32.8M | Buy |
45,991
+14,997
| +48% | +$10.7M | 0.06% | 278 |
|
|
2024
Q3 | $32.6M | Buy |
30,994
+7,360
| +31% | +$7.74M | 0.07% | 267 |
|
|
2024
Q2 | $24.8M | Buy |
23,634
+483
| +2% | +$508K | 0.06% | 292 |
|
|
2024
Q1 | $22.3M | Buy |
23,151
+2,412
| +12% | +$2.32M | 0.06% | 301 |
|
|
2023
Q4 | $18.2M | Buy |
20,739
+2,620
| +14% | +$2.3M | 0.05% | 321 |
|
|
2023
Q3 | $14.9M | Buy |
18,119
+13,248
| +272% | +$10.9M | 0.05% | 325 |
|
|
2023
Q2 | $3.5M | Buy |
4,871
+488
| +11% | +$351K | 0.04% | 153 |
|
|
2023
Q1 | $3.6M | Buy |
4,383
+235
| +6% | +$193K | 0.04% | 160 |
|
|
2022
Q4 | $3.06M | Buy |
+4,148
| New | +$3.06M | 0.04% | 150 |
|
|
2019
Q3 | – | Sell |
-5,173
| Closed | -$1.58M | – | 234 |
|
|
2019
Q2 | $1.58M | Buy |
5,173
+2,645
| +105% | +$809K | 0.07% | 112 |
|
|
2019
Q1 | $870K | Buy |
+2,528
| New | +$870K | 0.05% | 149 |
|
|
2017
Q2 | – | Sell |
-3,001
| Closed | -$1.16M | – | 182 |
|
|
2017
Q1 | $1.16M | Buy |
3,001
+916
| +44% | +$354K | 0.12% | 82 |
|
|
2016
Q4 | $766K | Sell |
2,085
-498
| -19% | -$183K | 0.09% | 109 |
|
|
2016
Q3 | $1.01M | Buy |
+2,583
| New | +$1.01M | 0.15% | 85 |
|